Mersana Therapeutics Inc (MRSN) — Capital Reinvestment Ratio
Mersana Therapeutics Inc (MRSN) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($54.60 Million) in capital expenditures ($426.00K). Check tangible net worth ratio of Mersana Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mersana Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Mersana Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Mersana Therapeutics Inc (MRSN) cash flow conversion.
Annual Capital Reinvestment Ratio for Mersana Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Mersana Therapeutics Inc from 2016 to 2016. See MRSN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $31.59 Million | $1.08 Million | — |